Cardiogenic Shock: Focus on Non-Cardiac Biomarkers
Hadi Beaini(The University of Texas Southwestern Medical Center), Maryjane Farr(Columbia University), Daniel Cheeran(Parkland Health & Hospital System), Jennifer T. Thibodeau(The University of Texas Southwestern Medical Center), L. Truby(Parkland Memorial Hospital), Christopher Wrobel(Parkland Memorial Hospital), Zainali Chunawala(Southwestern Medical Center), Faris Araj(Parkland Memorial Hospital), Amit Saha(Parkland Memorial Hospital)
Cited by 3
Related Papers
COVID-19 in solid organ transplant recipients: Initial report from the US epicenter
|American Journal of Transplantation|2020|837
Virtual Visits for Care of Patients with Heart Failure in the Era of COVID-19: A Statement from the Heart Failure Society of America
|Journal of Cardiac Failure|2020|193
International Society for Heart and Lung Transplantation Guidelines for the Evaluation and Care of Cardiac Transplant Candidates—2024
|The Journal of Heart and Lung Transplantation|2024|179
Impact of Female Sex on Cardiogenic Shock Outcomes
|JACC Heart Failure|2023|49
P2Y12 inhibitor versus aspirin monotherapy for secondary prevention of cardiovascular events: meta-analysis of randomized trials
|European Heart Journal Open|2022|39